Pith. sign in

REVIEW

Robust fractionation in cancer radiotherapy

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2108.03209 v1 pith:O57WG6I4 submitted 2021-08-06 math.OC

classification math.OC
keywords robustoptimalsolutioncancerderivedformulationfractionationlinear
verification ladder T0 review T1 audit T2 compute T3 formal

Signed reviews

No signed human review yet.

0 comments
read the original abstract

In cancer radiotherapy, the standard formulation of the optimal fractionation problem based on the linear-quadratic dose-response model is a non-convex quadratically constrained quadratic program (QCQP). An optimal solution for this QCQP can be derived by solving a two-variable linear program. Feasibility of this solution, however, crucially depends on the so-called alphaover-beta ratios for the organs-at-risk, whose true values are unknown. Consequently, the dosing schedule presumed optimal, in fact, may not even be feasible in practice. We address this by proposing a robust counterpart of the nominal formulation. We show that a robust solution can be derived by solving a small number of two-variable linear programs, each with a small number of constraints. We quantify the price of robustness, and compare the incidence and extent of infeasibility of the nominal and robust solutions via numerical experiments.

Discussion (0). Continue with ORCID to comment.

Pith tools